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Abstract
People with diabetes mellitus type 2 will have higher rate of cognitive impair-
ment than people that do not. Besides that, the effect of diabetes on the normal 
mental functions is often disregarded. This may be due to a lack of signs and 
standard assessment technique to measure the cognitive function of the diabetes 
patient. Hyperglycaemia which is common in people with diabetes has been associ-
ated with an increase in the possibility of developing Alzheimer’s disease and vas-
cular dementia in the both general public and people with cognitive impairment. It 
has been estimated that an individual with diabetes mellitus is 1.5 times more likely 
to experience cognitive dysfunction and dementia than a normal healthy individual. 
Alleviation of microvascular complications and hypoglycaemia is the key in treat-
ment of DM to prevent cognitive decline.
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1. Introduction
According to the International Diabetes Federation, diabetes is one of the largest 
global health emergencies of the twenty-first century and is the top 10 causes of 
death globally [1]. Diabetes mellitus (DM) is a disease in which the human body 
cannot produce sufficient amount of insulin and fails to respond to the hormone 
insulin that will result to the abnormal increase of glucose level in the blood circula-
tion resulting in hyperglycaemia [2]. It is a complex metabolic disorder which can 
damage multiple organs in the human body [3]. DM affects or even burdens indi-
vidual and communities with huge economic cost and leads to a decrease in overall 
productivity [4]. The complications of DM, especially type 2, can be enhanced by 
comorbidities such as hypertension, stroke, etc. [5]. Diabetes is the leading problem 
of kidney failure, lower-limb amputation and also blindness among adults [6]. In 
Malaysia, diabetes is one of the main public health problems and is closely related to 
avoidable and premature death [7].
The World Health Organization (WHO) divides the DM into two major cat-
egories which are insulin-dependent diabetes mellitus (IDDM) or type 1 diabetes 
mellitus and non-insulin-dependent diabetes mellitus (NIDDM) or type 2 diabetes 
mellitus [8]. Approximately 90% of all diabetes cases in both developed and 
developing countries are NIDDM and can be found mostly in people more than 
30 years old [9]. In type 1 DM, the pancreas cannot produce insulin, and the body 
has to completely rely on the synthetic insulin to reduce the glucose in the blood. 
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Type 1 DM is common in children, teenager as well as young adult [10]. DM can 
lead to complications such as diabetic nephropathy, diabetic retinopathy, ischaemic 
heart disease and many more [11]. The number of people with type 2 DM is increas-
ing in every country with 79% of people with DM living in low- and middle-income 
countries [12].
1.1 Global and Malaysian scenario of type 2 DM
Some 425 million people worldwide, or 8.8% of adults, are estimated to have 
diabetes [13]. About 79% lives in low- and middle-income countries. If these trends 
continue, by 2045, some 629 million people will have diabetes [13]. The estimated 
population of Malaysia in 2018 is 32.4 million [14]. There were almost 3.49 mil-
lion cases of diabetes in Malaysia in 2017 [15]. The percentage of population aged 
15–64 years old (working age) increases from 69.6% in 2017 to 69.7% in 2018. The 
percentage of 65 years and over (old age) population increases from 6.3 to 6.5% for 
the same period [14]. The number of deaths was divided into two groups of ages 
which are age between 30 and 69 years old as well as ages more than 70 years old. 
For example, the number of diabetes deaths for female ages more than 70 years old 
was 1260 people compared to 1070 for males [13].
2. Cognitive function
Cognitive function can be defined as mental process (cerebral activities) that lead 
to the gaining of knowledge which allows people to carry out their daily life activi-
ties [16]. Cognitive functions are mainly related to remembering, solving problems, 
making decision and understanding the language, problems or even issues like per-
sonal issues and health issues, focus, attention and others [2]. It also can be defined 
as memory which is tested by the stimuli either spoken or presented using another 
talking format or talking memory [17]. Moreover, it can be related to the large spec-
trum of cognitive capability among the middle- and old-aged group of people, which 
are having dementia as well as maintaining normal physiological function [18].
2.1 Relationship of cognitive function with type 2 DM
Cognitive impairment is a type of disorder which has not been studied and 
explored as the complications of DM. At the same time, the association of DM 
with cognition is well acknowledged. The meta-analysis shows small to moderate 
performance decline in persons with diabetes relative to nondiabetic controls in 
each domain examined. The motor function is largely affected, while attention/con-
centration is affected minimally [19]. Another study shows that people with type 2 
DM will have higher rate of cognitive impairment than people that do not have DM 
[20]. Besides that, the effect of diabetes on the normal mental functions is often 
disregarded. This may be due to lack of signs and standard assessment technique to 
measure the cognitive function of the diabetes patient [21]. Hyperglycaemia which 
is common in people with diabetes has been associated with an increase in the pos-
sibility of developing Alzheimer’s disease and vascular dementia in both the general 
public and people with cognitive impairment [22]. It has been estimated that an 
individual with DM is 1.5 times more likely to experience cognitive dysfunction and 
dementia than a normal healthy individual [23].
Elderly people who are more than 65-year-old will have more than 20% chances 
to be diagnosed with both DM and impaired cognitive function [24]. Type 2 
DM has been associated with few cognitive impairments such as decreases in 
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psychomotor speed, processing speed, visual retention, attention, concentration 
and many more. It is understood that more significantly hyperglycaemia, vascular 
disease, hypoglycaemia and insulin resistance affect cognitive decline, but the exact 
pathophysiological mechanisms not of cognitive decline in diabetes are unclear [3]. 
The causes of cognitive decline in diabetes may be the direct effect of the chronic 
hyperglycaemia on the brain regions, blood lipid, blood pressure, hypoglycaemia 
and others [25].
2.2 Duration of DM and cognitive impairment
Several studies have studied about the linkage of DM with cognitive decline 
in elderly population. A perspective (over 20 years) cohort study in the USA with 
mid-age (mean age 58) diabetic patient reported that DM in the midlife was related 
to a significant increase in cognitive impairment. This study included 13,351 black 
and white adults aged 48–67 years old, and their cognitive function was examined 
using three cognitive tests, which are the delayed-word-recall test (DWRT), the digit 
substitution test (DSST) of Wechsler Adult Intelligence Scale-Revised (WAIS-R) 
and the word fluency test (WFT). The study also reported that a patient with poorly 
controlled DM might have bigger cognitive disorder than well-controlled ones and 
longer duration of DM will have increased chances of late-life cognitive disorder [26].
A cross-sectional study was conducted on 57 patients having type 2 DM. The 
result shows that patients with type 2 DM had low grades in the cognitive testing 
and poor performance in different cognitive function tasks which include the verbal 
relations, visual reasoning, short-term memory test and many more. Cognitive 
function is impaired more with the untreated DM patient than the treated group 
[25]. Cognitive dysfunction is nonlinearly related to the duration of diabetes. 
However, cognitive decline is more prominent when the duration of DM is more 
than 5 years and presence of hypertension which further increases the risk of 
cognitive impairment [21]. The patients having diabetes showed poor performance 
in the tests of recent memory, repetition and attention, as compared to the control 
group and DM, and the people with long history of DM are more at risk of cogni-
tive decline [27]. It is concluded that cognitive function of diabetes type 2 patients 
should frequently be tested. This is because the duration of disease can be related 
with the decrease in cognitive function. As duration increases, impairment also 
increases [28].
2.3 Influence of age and cognitive impairment
A prospective study is done to observe and determine the impact of DM on the 
cognitive function impairment in the oldest of the old participants. The study was 
conducted using prospective population method. They have chosen approximately 
599 participants with the respond rate of 87% with the age ranges from 85 to 
90 years old. The memory function test does not show any differences between both 
diabetic and nondiabetic participants. Cognitive function of diabetic participants is 
affected when the time and speed test has been conducted [29].
The results of another research show that diabetic patients more than 65 years 
old have higher chances to be associated with impaired cognitive function [24]. 
Besides that, one more study was conducted that is related to assessing the status 
of cognitive function in people that have DM. The chosen patients were assessed by 
using MMSE and 3MS (the modified mini-mental state examination). The scores 
for both assessments were 30 and 100, respectively. At the same time, the relation-
ships of age, gender and duration of diabetes and HbA1c among the DM with 3MS 
will also be assessed. The results of this study were diabetic patients have lower 
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MMSE and 3MS than nondiabetic patients. This mean cognitive function will be 
reduced as the age increases and when having DM [30].
The uncontrolled DM which is one of the risk factors for cognitive impairment 
and dementia especially in Alzheimer patients. Therefore, controlling DM can 
reduce the possibility to get cognitive impairment and Alzheimer disease [5].
2.4 Association between duration of DM and age towards cognitive impairment
According to a homogenous cohort study on the community-dwelling women in 
11 US states. This study focusses on women that live in the community which are on 
their own compared to living in nursing or old folk home. The result of this research 
was participants (women) with type 2 DM had lower mean score in all the tests 
conducted than women without DM. At the same time, when duration has been 
diagnosed with DM and insufficiency in pharmacological treatment, it can worsen 
or cause increment in cognitive impairment. One of the limitations for this research 
is self-reporting regarding diabetes diagnosis [31].
Meanwhile, another study was done regarding the cognitive impairment in dia-
betic patients with special references to age of onset, duration and also control of 
diabetes. The study was conducted in diabetic patients that came to the medicine 
inpatient and outpatient departments and diabetic clinic of SSKM Hospital, India. 
It is used to calculate the mean effect of sugar control after a 6-month period. The 
result of this study was cognitive impairment has a relationship with diabetes. The 
cognitive function that usually affected were recognition, fluency and immediate 
memory power of the patients. Control of DM can help in improving cognitive 
function of the patients. Other habits such as smoking, poor control of sugar 
intake as well as life style can enhance the effect of cognitive impairment [32].
A cross-sectional study was conducted which is related to prevalence and 
predictors of cognitive dysfunction in type 2 DM population of Punjab, India. 
The study involves 516 type 2 DM participants that attended the endocrinology 
outpatient department of the Government Medical College and Hospital, Patiala, 
Punjab, India. The result of this study shows that many of diabetic participants that 
are living in Punjab, India, remain undiagnosed with cognitive impairment during 
their life. Cognitive impairment in diabetic participants is independently influenced 
by duration of diabetes, age of the patients and other complications besides diabetes 
such as hypertension and others [33].
2.5 HbA1c control and cognitive decline
HbA1c is recommended to be used to identify the people at risk of developing 
diabetes as well as to diagnose diabetes. It is the most important biomarker for the 
management of blood glucose control in individuals with already diagnosed diabe-
tes [34]. It is also a strong predictor for ensuing diabetes, because it incorporates the 
average blood glucose level over the last 2–3 months [35] and has better reliability 
than fasting or postprandial blood glucose test [36]. The cohort studies conducted 
in middle-aged populations show that the cognitive decline in people with diabetes 
is significantly faster than those with normal blood glucose levels [26, 37]. The 
study also reported that there is no significant difference in cognitive decline in 
people with prediabetes than in those with normal blood glucose levels [13]. On 
the contrary, the other study reported significantly faster cognitive decline among 
people with prediabetes than those with normal HbA1c levels [26]. The longitudinal 
study done reported significant longitudinal associations between HbA1c levels, 
diabetes status and long-term cognitive decline [38].
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3. Cognitive deficits in patients with type 1 and type 2 DM
The cognitive domains that were negatively affected have been identified in 
patients with type 1 and type 2 DM with strong supporting data (Table 1).
The cognitive domains that were negatively affected have been identified in 
patients with type 1 and type 2 DM with less supporting data (Table 2).
3.1 Physiological pathways linking diabetes and cognition
The link between diabetes and cognitive impairment was first reported in 1922 
[58]. The exact physiologic pathways linking the two conditions remain unclear. The 
hypothetical mechanisms include which is related to cerebrovascular complications, 
neuronal glucose processing and frequent episodes of hypoglycaemia [3, 59, 60]. 
The diabetic patients are more prone to develop comorbid cardiovascular disease, 
which is itself predictive of cognitive decline through cerebrovascular events and 
other pathways [61].
3.2 Treatment strategy
There are some complications of type 2 DM that affect the brain; it is believed 
that diabetes treatment may have beneficial effects on cognition. Three different 
trials reported that intensive glycaemic control alleviate microvascular complica-
tions but does not alleviate macrovascular complications in geriatric patients 
with long-duration of type 2 diabetes and high cardiovascular risk [62–64]. The 
intensive treatment of type 2 DM leads to hypoglycaemia which may contribute 
to cognitive decline and eliminate the benefits of intensive treatment [63, 65, 66]. 
Hypoglycaemia is more common in intensive glycaemic control than in standard 
glycaemic control [67].
Type 1 DM Type 2 DM
Slowing of information processing [39–42]
Psychomotor efficiency [39, 40, 44]
Attention [42]
Visuoconstruction [42]
Psychomotor speed [43]
Memory
Working memory [45, 46]
Verbal memory [47]
Immediate recall
Delayed recall [31]
Executive function [43, 45, 46]
Table 1. 
Cognitive domains affected by type 1 and type 2 DM (with strong supporting data).
Type 1 DM Type 2 DM
Memory [44]
Motor speed [41, 49–51]
Vocabulary [44, 52–54]
General intelligence [53, 54]
Visual perception
Motor strength [51]
Executive function [49, 57]
Verbal fluency [43, 48]
Complex motor function [43]
Processing speed [47]
Attention [55]
Depression [45, 56]
Table 2. 
Cognitive domains affected by type 1 and type 2 DM (with less supporting data).
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4. Conclusion
DM is an important risk factor along with other diabetic complications for 
cognitive decline, which leads to loss of independence and nonadherence to medica-
tion and results in high healthcare cost. It is still controversial how early the age 
of cognitive impairment is, although there is enough documented links between 
diabetes and cognitive function. The standard glycaemic control is better than 
intensive glycaemic control in the prevention of cognitive decline. The challenge 
for treatment is to maintain the cognitive function by reduction of hypoglycaemic 
events.
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